Because Dextroamphetamine is an amphetamine, the drug is classified under the terms of the Controlled Substances Act of 1970 as a Schedule II drug. Schedule II drugs are regarded as prescription medications that yield a genuine medical benefit, but also pose a high risk for addiction and abuse. Dextroamphetamine is far more potent than racemic amphetamine and has a number of stimulant properties to racemic methamphetamines. Dextroamphetamine is the leading ingredient in the ADHD combatant Adderall, which is composed of racemic